Santa Casa De Misericordia DA Bahia

Santa Casa De Misericordia DA Bahia, doing business as Administracao Central, is a tax-exempt nonprofit hospital organization based in Salvador, Brazil, that participates in federal biomedical research as a sub-recipient on National Institutes of Health grants. The vendor operates exclusively in a subcontractor capacity (100% of recent awards) and holds no federal contract prime awardees or contract vehicle seats.

Santa Casa De Misericordia functions as a research site and clinical partner on infectious-disease and pulmonary-hypertension studies funded through the Department of Health and Human Services, National Institutes of Health, National Heart Lung and Blood Institute. All three recorded federal awards flow from The Regents of the University of California, San Francisco as the prime grantee. The vendor's scope spans patient enrollment, screening, echocardiographic evaluation, biospecimen collection and banking, regulatory compliance, and data entry into the REDCap database for studies of schistosomiasis-associated pulmonary arterial hypertension (SchPAH) and schistosomiasis-associated hepatosplenic disease (SchHSD) in a Brazilian patient population. The three sub-awards, dated May 2023, April 2025, and April 2026, carry a combined obligation of $346 thousand across the funding window.

Activity shows one award per year from 2023 through 2026, with no indication of volume growth or contraction. The vendor's federal footprint is narrowly concentrated — a single customer agency (NIH/NHLBI) and a single prime partner (UC San Francisco) — creating no material competitive exposure to federal contractors in the United States market but positioning the vendor as a potential sub-recipient partner on international or international-site clinical research initiatives sponsored by NIH.